Updated Jul 16, 2026
TANG KEVIN has filed 6 SEC Form 4 filings across 3 companies in the last 90 days — buying. Lifetime open-market purchases: $51.79M. Historical track record: 3/5 stars across 12 tracked purchases.

| Role | Insider |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★☆☆ (3/5) |
|---|---|
| Total purchases tracked | 12 |
| Purchases with forward-return data | 12 |
| 30-day win rate | 5000% |
| 90-day win rate | 7500% |
| Avg 5-day return | +555.65% |
| Avg 30-day return | +223.57% |
| Avg 90-day return | +588.50% |
| Best 30-day return | +1134.41% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-15 | FULC | Fulcrum Therapeutics, Inc. | P — Open-market purchase | 107.4K | $3.56 | $382K |
| 2026-07-15 | FULC | Fulcrum Therapeutics, Inc. | P — Open-market purchase | 76.0K | $3.58 | $272K |
| 2026-07-15 | FULC | Fulcrum Therapeutics, Inc. | P — Open-market purchase | 53.7K | $3.56 | $191K |
| 2026-07-15 | FULC | Fulcrum Therapeutics, Inc. | P — Open-market purchase | 13.0K | $3.54 | $46K |
| 2026-07-13 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 48.2K | $2.42 | $117K |
| 2026-07-13 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 43.4K | $2.43 | $105K |
| 2026-07-13 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 7 | $2.48 | $17 |
| 2026-07-09 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 14.3K | $2.46 | $35K |
| 2026-07-09 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 15.8K | $2.48 | $39K |
| 2026-07-09 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 27.1K | $2.49 | $67K |
| 2026-07-02 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 9.8K | $2.49 | $24K |
| 2026-07-02 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 71.6K | $2.49 | $178K |
| 2026-07-02 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 100 | $2.50 | $250 |
| 2026-07-02 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 25.9K | $2.54 | $66K |
| 2026-06-29 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 777 | $2.48 | $2K |
| 2026-06-29 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 64.0K | $2.47 | $158K |
| 2026-06-29 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 134 | $2.54 | $340 |
| 2026-06-29 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 75.0K | $2.55 | $191K |
| 2026-06-29 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 510 | $2.56 | $1K |
| 2026-06-29 | BOLD | Boundless Bio, Inc. | P — Open-market purchase | 145.9K | $2.48 | $362K |
TANG KEVIN is a corporate insider — currently tracked as Insider of Fulcrum Therapeutics, Inc. (FULC). InsiderAlpha tracks every SEC Form 4 filing in real time.
6 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 37 open-market purchases ($51.79M) and 0 open-market sales () across all tracked filings.
Across 12 tracked purchases, TANG KEVIN averaged +223.6% avg 30-day return with a 5000% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live TANG KEVIN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.